Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kreft-Jais

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|December 15, 1992
[Do converting enzyme inhibitors differ from each other in the treatment of hypertension?]S Laurent, E Billaud, C Kreft-Jais
Therapie|November 1, 1993
[Calcium antagonists and arterial hypertension]S Laurent, E Billaud, C Kreft-Jais
Therapie|November 9, 2002
[Retrospective of national pharmacovigilance surveys on drug-induced bullous, vesicular eruptions: methods and results ]A Escousse, M J Jean-Pastor, C Kreft-Jais
The British Journal of Dermatology|January 31, 2012
Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literatureB Lebrun-Vignes, C Kreft-Jais, A Castot, et al.
Therapie|July 1, 1992
[Critical analysis of drug interactions with cyclosporine. Evaluation of interactions with cyclosporine]E M Billaud, J Ropers, N Fortineau, et al.
Therapie|November 1, 1995
[French pharmacovigilance database system: examples of utilisation]N Moore, C Noblet, C Kreft-Jais, et al.
British Journal of Clinical Pharmacology|February 12, 1998
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system databaseN Moore, C Kreft-Jais, F Haramburu, et al.
Presse Medicale (Paris, France : 1983)|December 3, 1988
[Clinical evaluation of drug interactions of cyclosporin]E M Billaud, C Kreft-Jais, F De la Tour du Pin, et al.
The American Journal of Cardiology|October 1, 1987
Efficacy and tolerance of spironolactone in essential hypertensionX Jeunemaitre, G Chatellier, C Kreft-Jais, et al.
Transplantation|October 1, 1993
Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantationJ Julien, D Farge, C Kreft-Jais, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|December 15, 1992
[Do converting enzyme inhibitors differ from each other in the treatment of hypertension?]S Laurent, E Billaud, C Kreft-Jais
Therapie|November 1, 1993
[Calcium antagonists and arterial hypertension]S Laurent, E Billaud, C Kreft-Jais
Therapie|November 9, 2002
[Retrospective of national pharmacovigilance surveys on drug-induced bullous, vesicular eruptions: methods and results ]A Escousse, M J Jean-Pastor, C Kreft-Jais
The British Journal of Dermatology|January 31, 2012
Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literatureB Lebrun-Vignes, C Kreft-Jais, A Castot, et al.
Therapie|July 1, 1992
[Critical analysis of drug interactions with cyclosporine. Evaluation of interactions with cyclosporine]E M Billaud, J Ropers, N Fortineau, et al.
Therapie|November 1, 1995
[French pharmacovigilance database system: examples of utilisation]N Moore, C Noblet, C Kreft-Jais, et al.
British Journal of Clinical Pharmacology|February 12, 1998
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system databaseN Moore, C Kreft-Jais, F Haramburu, et al.
Presse Medicale (Paris, France : 1983)|December 3, 1988
[Clinical evaluation of drug interactions of cyclosporin]E M Billaud, C Kreft-Jais, F De la Tour du Pin, et al.
The American Journal of Cardiology|October 1, 1987
Efficacy and tolerance of spironolactone in essential hypertensionX Jeunemaitre, G Chatellier, C Kreft-Jais, et al.
Transplantation|October 1, 1993
Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantationJ Julien, D Farge, C Kreft-Jais, et al.
Pageof 2